Milan, Italy

Sergio Tomaselli

This inventor holds 1 USPTO granted patent. Top assignee: Antibioticos. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sergio Tomaselli

Introduction

Sergio Tomaselli is a notable inventor based in Milan, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of enzymatic processes. His work has implications for the pharmaceutical industry, especially in antibiotic production.

Latest Patents

Sergio Tomaselli holds a patent for an "Enzymatic process for preparing 7-aminocephalosporanic acid." This innovative method involves the transformation of Cephalosporin C or its derivatives and salts into 7-aminocephalosporanic acid or its derivatives through an enzymatic two-stage process with enzymes immobilized on a solid matrix. This patent highlights his expertise in enzymatic reactions and their applications in drug development.

Career Highlights

Sergio Tomaselli is associated with Antibioticos, a company that focuses on the production of antibiotics. His work at Antibioticos has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in antibiotic manufacturing. With a total of 1 patent, he has established himself as a key figure in his field.

Collaborations

Sergio has collaborated with notable colleagues such as Stefano Cambiaghi and Roberto Verga. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sergio Tomaselli's contributions to the field of biochemistry and his innovative patent demonstrate his commitment to advancing antibiotic production. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…